Self-expanding metallic stents provide excellent palliation of inoperable m
alignant dysphagia with minimal morbidity; in many centres they now represe
nt the treatment of choice. Covered stents represent the only reliable opti
on in the management of malignant fistulae and are highly successful in thi
s situation. Placement of stents at the oesophago-gastric junction remains
problematic. Covered stents placed at this site have a high migration rate
and uncovered stents have a relatively high incidence of tumour ingrowth. N
ew developments, such as the Flamingo stent, may prove helpful in this area
.